B+
Bull case
25%
Probability
Target price
$14.48
-1.6% vs current
Aggregated analyst targets show a modestly constructive median above the current price but a narrow spread, implying limited upside concentrated near the high target. Near‑term sentiment hinges on the upcoming quarterly print and subsequent analyst responses.
No evidence quality warning is currently attached to this memo.
Quarterly consensus refreshes could reprice the stock within a 12‑month window as analysts update targets.
FY2025 results and guidance will likely prompt analyst updates and reorder near‑term expectations.
Sustained roadmap execution and margin recovery would support re‑rating over a year if commercial traction materializes.
No formal recommendation provided.